| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 117 |
| 1 | RITUXIMAB | 80 |
| 2 | ETANERCEPT | 79 |
| 3 | ABATACEPT | 78 |
| 4 | INFLIXIMAB | 78 |
| 5 | TOCILIZUMAB | 78 |
| 6 | LEFLUNOMIDE | 76 |
| 7 | SULFASALAZINE | 76 |
| 8 | METHOTREXATE SODIUM | 74 |
| 9 | HYDROXYCHLOROQUINE SULFATE | 72 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLD | 51 | 0.0088 |
| 1 | MINOCYCLINE HYDROCHLORIDE | 42 | 0.0071 |
| 2 | CANAKINUMAB | 50 | 0.0046 |
| 3 | TRILACICLIB | 1 | 0.0041 |
| 4 | TRASTUZUMAB-DKST | 1 | 0.0036 |
| 5 | ACETYLSALICYCLIC ACID | 1 | 0.0034 |
| 6 | MINOCYCLINE | 36 | 0.0031 |
| 7 | ANAKINRA | 51 | 0.0030 |
| 8 | PEGFILGRASTIM-JMDB | 1 | 0.0022 |
| 9 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 1 | 0.0012 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 51 | 0.0030 |
| 1 | Aminosalicylate [EPC] | 76 | 0.0008 |
| 2 | Antirheumatic Agent [EPC] | 76 | 0.0007 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 78 | 0.0006 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 78 | 0.0006 |
| 5 | Vitamin D2 Analog [EPC] | 3 | 0.0004 |
| 6 | Tetracycline-class Drug [EPC] | 26 | 0.0004 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 83 | 0.0003 |
| 8 | Anticholinergic [EPC] | 4 | 0.0002 |
| 9 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |